Major Update to the COVID-19 Treatment Guidelines

The COVID-19 Treatment Guidelines Panel (the Panel) has published a major update to the Coronavirus Disease 2019 (COVID-19) Treatment Guidelines.

Key changes in this version of the Guidelines include the addition of a new section titled Special Considerations in People Who Are Immunocompromised. This section covers methods of preventing SARS-CoV-2 infection and discusses key considerations for clinicians who are managing patients with COVID-19 who are immunocompromised. Among other populations, this includes people who have advanced or untreated HIV infection, defined as people with HIV and CD4 T lymphocyte [CD4] cell counts <200 cells/mm3, a history of an AIDS-defining illness without immune reconstitution, or clinical manifestations of symptomatic HIV.
The revised document includes many other important updates to ensure that health care providers, patients, and policy experts have the most recent information regarding the optimal management of COVID-19.

For full details, please see What's New in the Guidelines on the COVID-19 Treatment Guidelines website.